Nivolumab Effective for Gastric and Lung Cancers but Not for Multiple Myeloma in a Multiple Primary Cancer Patient

Table 1

Laboratory data at the time of diagnosis of gastric cancer and lung cancer.

		Units	Reference range
Hematology
WBC	7,300	μL	4,000–9,000
Neut	52	%	38.0–71.9
Eos	2.0	%	0.2–6.8
Ba	0.0	%	0.0–1.0
Mono	8.0	%	2.3–7.7
Lymph	38	%	26.0–46.6
RBC	329	×10^4/μL	410–560
Hb	11.1	g/dL	13.5–17.5
Ht	33.5	%	40.0–53.0
MCV	89.6	fL	80.0–100.0
Platelets	20.1	×10^4/μL	14.0–40.0
Biochemistry
TP	5.3	g/dL	6.7–8.3
Alb	3.6	g/dL	4.0–5.0
T-bil	0.4	mg/dL	0.3–1.2
AST	16	U/L	13–33
ALT	27	U/L	6–30
LDH	243	U/L	119–229
γ-GTP	106	U/L	10–47
BUN	14.9	mg/dL	8.0–22.0
Cre	0.86	mg/dL	0.60–1.10
Na	142	mmol/L	138–146
K	3.7	mmol/L	3.6–4.9
Cl	110	mmol/L	99–109
Ca	8.9	mg/dL	8.7–10.3
P	3.1	mg/dL	2.5–4.7
IgG	453	mg/dL	870–1700
IgA	33	mg/dL	110–410
IgM	21	mg/dL	35–220
IgD	10.5	mg/dL	<9.0
Tumor markers
CEA	2.4	ng/mL	<5.0
CYFRA	1.4	ng/mL	<3.5
Pro-GRP	66.6	pg/mL	<81.0
Urinalysis
Protein	0.22	g/gCr	<0.15
RBC	(—)
WBC	(—)

WBC: white blood cells; Neut: neutrophils; Eos: eosinophils; Ba: basophils; Mono: monocytes; Lymph: lymphocytes; RBC: red blood cells; Hb: hemoglobin; Ht: hematocrit; MCV: mean corpuscular volume; TP: total protein; Alb: albumin; T-Bil: total bilirubin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; LDH: lactate dehydrogenase; γ-GTP: gamma-glutamyl transpeptidase; BUN: blood urea nitrogen; Cre: creatinine; Na: sodium; K: potassium; Cl: chloride; Ca: calcium; P: phosphorus; IgG: immunoglobulin G; IgA: immunoglobulin A; IgM: immunoglobulin M; IgD: immunoglobulin D; CEA: carcinoembryonic antigen; CYFRA: cytokeratin-19; Pro-GRP: progastrin releasing peptide.